People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

Recruiting now · Not applicable

Conditions studied: Osteoporosis

In brief

The aim of the Walk BEST study is to provide evidence that it is feasible to implement the technology assisted gait- focused walking program Walk-BEST™ in older adults with osteoporosis, and that this program is acceptable to this population.

Key facts

Study ID

NCT07621679

Run by

McGill University Health Centre/Research Institute of the McGill University Health Centre

People needed

28

Starts

2026-05-07

Expected to finish

2027-05-01

Last updated by the study team

2026-06-02

Who can join

Age: 70 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• men and women 70 years and older
• able to walk independently with or without a walking aid
• experienced a prior fracture after the age of 40, OR two falls in the past 12 months, OR who have a bone mineral density test (done as part of routine clinical evaluation) with a T-score < -2.5, OR on a Health Canada-approved anti-osteoporosis medication (oral or intravenous bisphosphonate, denosumab, teriparatide, or romozosumab) to reduce fracture risk or on a bisphosphonate drug holiday (planned treatment interruption)

You may not qualify if…

• fracture sustained in the past 12 months
• unable to walk unsupervised because of active medical or neurocognitive reasons
• unable to provide informed consent, or cannot communicate in English or French

Where it is running

• Research Institute of the McGill University Health Centre — Montreal, Quebec, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.